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Abstract
Objective. The aim of our study was to conduct a retrospective investigation of the efficacy of laparoscopic Nissen
fundoplication in patients with Barrett’s esophagus. Material and methods. A total of 78 patients with Barrett’s esophagus
underwent surgery. Patients were divided into three groups on the basis of the preoperative endoscopic biopsies: a non-
intestinal group (n = 63) with fundic or cardiac metaplasia, an intestinal group (n = 18) with intestinal metaplasia, and a
dysplastic group (n = 7) with low-grade dysplasia. Clinical follow-up was available in the case of 64 patients at a mean of 42 ±
16.9 months after surgery. Results. Check-up examination revealed total regression of Barrett’s metaplasia in 10 patients.
Partial regression was seen in 9 cases, no further progression in 34 patients, and progression into cardiac or intestinal
metaplasia in 11 patients. No cases of dysplastic or malignant transformation were registered. Where we observed the
regression of BE, among the postoperative functional examinations results of manometry (pressure of lower esophageal
sphincter) and pH-metry were significantly better compared with those groups where no changes occurred in BE, or
progression of BE was found. Discussion.Our results highlight the importance of the cases of fundic and cardiac metaplasia,
which can also transform into intestinal metaplasia. Conclusions. Antireflux surgery can appropriately control the reflux
disease in a majority of the patients who had unsuccessful medical treatment, and it may inhibit the progression and induce the
regression of Barrett’s metaplasia in a significant proportion of these patients.
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Introduction
Barrett’s esophagus (BE) is a premalignant condition
which is thought to progress from Barrett’s metaplasia
(BM) through low-grade dysplasia (LGD) to high-
grade dysplasia (HGD) and subsequently to adeno-
carcinoma [1–5]. The estimated annual risk for
adenocarcinoma in subjects with BE ranges from
0.2% to 2.0%, a risk that is 30–125 times that of
the general age-matched population [6–8].
BE is associated with gastro-esophageal reflux dis-
ease (GERD): it is found in 15–20% of patients with
GERD [9,10]. The incidence of BE appears to have
risen dramatically in the past 20 years [11], a fact that
has been linked to the 10-fold increase observed in the
incidence of adenocarcinoma of the esophagus during
the last decade [12]. All of these facts underline the
importance of the need for the correct treatment
of BE.
The aim of treatment for BE is to bring the symp-
toms under control, cure the associated inflammatory
lesions, and prevent the appearance of dysplasia
and adenocarcinoma. The therapeutic options are
life-long medical treatment or antireflux surgery.
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Although both these options are equally efficient in
controlling the symptoms, some clinical studies sug-
gest that effective surgical treatment leads to a higher
rate of cure of the associated inflammatory lesions
[13,14]. Surgical treatment is also better than medical
treatment in preventing BE from progressing into
adenocarcinoma [13,15,16]. Laparoscopic antireflux
procedures are generally accepted surgical methods
for the treatment of patients with GERD and BE with
the exception of HGD.
The aim of our study was to conduct a retrospective
investigation of the efficacy of laparoscopic Nissen
fundoplication in patients with BE.
Materials and methods
In all, 78 consecutive patients with symptomatic BE
underwent laparoscopic Nissen fundoplication in our
institution between 2001 and 2008, 40 males and
38 females, with a median age of 53 years (range:
24–78). The mean body mass index (BMI) was 28.3 ±
5.4 (range: 19.8–37). All of the patients had previ-
ously participated in unsuccessful proton-pump
inhibitor (PPI) treatment for persistent reflux symp-
toms and BM for an average of 20 ± 2.73 months
(range: 7 months to 14 years). The mean length of
time between the first symptoms and the beginning of
medical treatment was 3.65 ± 4.67 years (range:
8 months to 20 years). Hiatus hernia was observed
in 50 cases (64.1%) with a mean size of 3.93 ± 1.95 cm
(range: 2–8).
Patients were divided into three groups on the basis
of the histological results of their preoperative
endoscopic biopsies: a non-intestinal group (NI,
63 patients) with fundic (FM) and cardiac metaplasias
(CM), an intestinal group (I, 18 patients) with intes-
tinal metaplasia (IM), and a dysplastic group
(D, 7 patients) with LGD. BE involved a short seg-
ment (<3 cm, SSBE) in 67 (85.9%) of the cases and a
long segment (>3 cm, LSBE) in 11 (14.1%) patients.
Our retrospective study was approved by the ethical
committee of the University of Szeged.
Assessment of symptoms and objective measures
of outcome
We have compared the results of preoperative func-
tional examinations, BMI, the extent of hiatus hernia,
duration of reflux symptoms, and the length of PPI
therapy, looking for connection with severity of BE
(NI, I, and D groups) in case of all patients to be
operated (n = 78).
Postoperative endoscopy was performed in
64 patients (82%, 64/78); 14 patients who did not
participate in upper gastrointestinal endoscopy were
excluded from the comparison of the pre- and post-
operative functional examinations and the postoper-
ative endoscopic long-term analysis.
Postoperative functional examinations, such as
esophageal manometry, 24-h pH-metry, and bile
exposure (Bilitec) monitoring, were performed in
the early postoperative period with an average
follow-up time of 16.7 ± 17 months (range: 3–23).
In the later postoperative period, a further upper
endoscopy with biopsy was carried out to check the
changes in BE. The overall average follow-up time
was 42 ± 16.19 months (range: 3–61).
The results of the pre- and postoperative medical
examinations in the three groups were compared to
identify the possible factors that promote the malig-
nant transformation of BE into an adenocarcinoma.
The efficacy of laparoscopic surgery was studied
with regard to the regression or progression of BM or
LGD on histology, the lower esophageal sphincter
(LES) function, and the postoperative 24-h pH-
metry and bile exposure findings.
Clinical investigation
Visick grading was used to assess the effect of surgery
on the symptoms: complete resolution (Grade I); an
improvement (Grade II); no effect of surgery (Grade
III); or deterioration relative to the preoperative state
(Grade IV). This scoring system was devised to give an
overall impression of the benefits of antireflux surgery
because it exhibits good correlation with heartburn, the
most prominent symptom of GERD [17,18].
Endoscopy
The presence of BE (as a result of reflux) was con-
firmed by endoscopy and histological examination of
the biopsy samples.
The location of the gastro-esophageal junction was
defined as the point where the proximal extent of the
gastric rugal folds met the tubular esophagus. Accord-
ing to the Prague C&M criteria [19], the length of
Barrett’s epithelium is measured from this point to the
highest point of the squamocolumnar junction. The
level of the diaphragmwas also recorded.Hiatal hernia
was diagnosed when the crural impression was sepa-
rated from the top of the gastric rugal folds by >2 cm.
The size of the hiatus hernia was recorded in centi-
meters. Biopsies were taken from the columnar
mucosa at 2-cm intervals in a four-quadrant fashion.
Histopathology
The specimens were processed separately by formalin
fixation and paraffin embedding for hematoxylin
14 Z. Simonka et al.
Sc
an
d 
J G
as
tro
en
te
ro
l D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
U
ni
ve
rs
ity
 o
f S
ze
ge
d 
on
 0
1/
17
/1
2
Fo
r p
er
so
na
l u
se
 o
nl
y.
and eosin staining, and immunohistochemistry was
performed to identify the type of columnar metapla-
sia. The same expert pathologist reviewed all biopsy
specimens. When HGDwas suspected, the opinion of
a second independent pathologist was sought to con-
firm the diagnosis. The pathologists were blinded to
the treatment regimen.
Esophageal manometry
Standard water perfusion stationary manometry was
performed according to the Castell criteria [20–23].
The manometric catheter was introduced into the
esophagus through the nares. The motility of the
LES, the esophageal body, the upper esophageal
sphincter, and the pharynx was evaluated. The
sphincters were studied by the station pull-
through technique. Esophageal body peristalsis was
also assessed during wet and dry swallows.
24-h esophageal pH monitoring
The procedure was performed on an inpatient
basis, following the previously published protocol
of our laboratory [24]. A naso-esophageal pH
probe was positioned in the distal esophagus, at
5 cm above the LES, and the esophageal pH was
recorded for 24 h. Esophageal pH parameters were
analyzed with regard to the DeMeester’s standards
[20,25–27].
24-h esophageal bile exposure (Bilitec) monitoring
The procedure was performed simultaneously with
the 24-h pH-monitoring study. A naso-esophageal
fiberoptic catheter was positioned in the distal esoph-
agus, at 5 cm above the LES, and the optical density at
450 nm of the esophageal content was recorded for
24 h [20,25–27].
Bilitec was carried out only in the selected cases
(51 patients) in which a biliary reflux (duodeno-gastro-
esophageal reflux) was proved by endoscopy.
Surgery
All patients underwent standard laparoscopic 360
Nissen fundoplication. The operation took place in
all cases after full mobilization of the esophagus,
division of the short gastric vessels, and posterior
crural repair. At the time of the construction of the
wrap, a 57 F bougie was introduced through the
esophagus. The operation was always performed by
the same team of surgeons.
Statistical analysis
Statistical computations were performed with an
SPSS 17.0 for Windows software package, while
the special Poisson distributed ANOVA method
was performed with SAS for Windows 9.1. [28].
Preoperative univariate analyses were performed to
identify factors associated with the occurrence of
histopathological progression: a non-parametric
method (Kruskal–Wallis test) was used for the anal-
ysis of variables. Non-parametric univariate analyses
(Mann–Whitney test) were performed to estimate the
efficacy of laparoscopic antireflux surgery, comparing
the variables before and after surgery. To compare
changes in the patients’ parameters before and after
the operation in the three groups, a generalized mixed
model repeated measurements ANOVA method was
applied (multivariate analysis) using the GLIMMIX
procedure of SAS 9.1. One repeated measurement
factor (antireflux surgery), one independent factor
(groups), and their interaction were examined. The
distribution of the variables and the differences of
variations in the three groups were also taken into
account. P values < 0.05 were considered statistically
significant.
Results
Preoperative characteristics of the patient population
In contrast to expectations, IM and LGD did not
display a longer history of reflux disease as compared
with that in the NI group, whereas the history in the
NI group started earlier than in the I group (p = 0.057)
(Table I). The duration of medical treatments showed
no differences either. Though patients in all three
groups were overweight, the average BMI values
did not differ. Hiatus hernia was present with the
same incidence in cases of more severe BM and LGD,
but it was not significantly higher than in the NI
group. No statistical difference was detected in the
three groups with respect to the functioning of the
LES such as pressure, length, and relaxation time.
Corresponding with the data in literature, our earlier
research results revealed more severe acid reflux in
patients with BE than in patients with milder GERD
alone. With respect to the acid reflux, however, BE
did not exhibit any difference. The DeMeester score
parameters used to calculate the score did not differ
significantly in the three groups. In comparison with
the NI group, a higher DeMeester score was observed
only in the D group, but this difference was not
significant. The majority of the values measured dur-
ing the Bilitec examination indicated more severe
Surgery – Barrett’s esophagus 15
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Table I. Characteristics of the three preoperative groups (NI, I, and D) (78 patients).
Group Mean SD p Value
Patients’ characteristics BMI NI 27.70 5.58 0.354
I 29.93 5.67
D 28.30 4.09
Hiatal hernia (cm) NI 3.07 1.95 0.395
I 3.08 2.4
D 4.20 1.17
The mean length of time (y) between
the appearance of first symptoms and surgery
NI 5.80 4.53 0.057
I 3.94 5.25
D 4.29 5.15
PPI’s treatment (y) NI 1.47 2.56 0.537
I 1.00 0.97
D 4.14 5.27
Manometry pLES (mmHg) NI 11.27 8.19 0.382
I 13.31 8.84
D 8.40 8.85
rLES (s) NI 10.51 3.32 0.937
I 10.09 1.97
D 10.00 0.82
lLES (cm) NI 2.98 1.37 0.757
I 3.54 1.90
D 3.00 0.82
pH-metry Time of acid exposure <pH 4 NI 100.64 78.11 0.835
I 111.12 104.80
D 274.20 359.82
Upright acid exposure <pH 4 NI 80.10 70.91 0.832
I 93.18 92.16
D 229.00 302.06
Supine acid exposure <pH 4 NI 20.67 25.10 0.374
I 18.35 29.21
D 45.60 60.65
Postprandial acid exposure <pH 4 NI 47.28 38.05 0.748
I 50.88 55.35
D 113.20 136.51
>5 min acid exposure <pH 4 NI 3.90 4.76 0.299
I 5.06 10.05
D 8.00 8.80
Longest acid exposure <pH 4 NI 25.10 60.13 0.469
I 15.24 20.97
D 43.20 48.98
DeMeester score NI 34.95 43.84 0.145
I 39.12 61.01
D 88.92 67.58
Bilitec Time of bile exposure NI 22.38 22.90 0.025
I 23.33 30.53
D* 70.75 32.52
Upright bile exposure NI 13.88 17.64 0.027
I 16.60 15.77
D* 48.75 28.36
Supine bile exposure NI 8.66 12.16 0.017
I 6.80 19.04
D* 23.00 14.90
Postprandial bile exposure NI 6.78 9.30 0.087
I 8.00 7.85
D 20.50 16.84
>5 min bile exposure NI 6.97 10.27 0.021
I 3.00 2.90
D* 17.50 14.39
Longest bile exposure NI 87.16 107.20 0.195
I 38.60 63.72
D 111.25 37.95
*Comparison of the preoperative groups revealed significantly more severe biliary reflux in the D group than in the other two groups (Non-
parametric method – the Kruskal–Wallis test – was applied).
Abbreviations: BMI = body mass index; D = dysplastic (group); I = intestinal (group); lLES = length of lower esophageal sphincter; NI = non-
intestinal (group); pLES = pressure of lower esophageal sphincter; PPI = proton-pump inhibitor; rLES = relaxation time of lower esophageal
sphincter.
16 Z. Simonka et al.
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biliary reflux in the D group than in the other two
groups (Table II). In contrast with the results of the
univariate analyses, the multivariate analysis did not
demonstrate significant differences in the three pre-
operative groups (data not shown).
Operative and early postoperative results
The average operation time was 99 ± 67.40 min.
Conversion to open surgery was necessary in one
patient (1.3%). There were no major intraoperative
complications or deaths. The mean duration of hos-
pitalization was 3 ± 1 days.
Early postoperative results
Symptomatic outcome
The Visick score, which reflects the complaints relat-
ing to the reflux, indicated that the patients’ com-
plaints were alleviated or ceased in 81% of the cases,
remained unaltered in 15%, and worsened in only 4%
of the patients. The Visick score varied somewhat
within the groups; for the patients with intestinal
BM and also those with LGD, complaints were alle-
viated relative to those in the group with NI meta-
plasia. The assessment of the changes in both the
subjective and objective complaints demonstrated
that the symptoms recorded during the preoperative
period tended to be relieved after laparoscopic Nissen
fundoplication. In accordance with our expectations,
dysphagia increased.
Postoperative functional examinations (manomentry,
24-h pH studies, and Bilitec)
Postoperative manometry, pH-metry, and Bilitec did
not reveal statistically significant differences in the
three groups. Changes in the functioning of the LES,
which also indicate the efficacy of the operation,
demonstrated that the postoperative pressure in the
lower esophagus was significantly increased relative to
that preoperatively, while the relaxation time
remained unchanged (Table I). In consequence of
the surgical technique (a loose and narrow Nissen
floppy), the length of the LES was unchanged after
fundoplication, but its functioning (pressure) was
restored, thereby preventing acid and biliary reflux.
Comparison of the results of pH-metry before and
after the operation in the three groups confirmed the
above findings, as the average DeMeester scores were
clearly decreased after the operation. Accordingly, the
incidence and severity of the biliary reflux were
reduced, or this symptom was eliminated (Table
II). Multivariate analysis proved significant changes
between the preoperative and postoperative groups
only as concerns the pressure of the LES and the
results of pH-metry (data not shown).
Endoscopic surveillance
The mean duration of endoscopic follow-up was 42 ±
16.19 months. Postoperative endoscopy was per-
formed in 64 patients (82%, 64/78). Fourteen patients
who did not participate in upper gastrointestinal
Table II. Pre- and postoperative results of functional examinations (64 patients).
Preoperative Postoperative
Mean SD Mean SD p Value
Manometry pLES (mmHg) 11.46 8.32 19.35 6.92 £ 0.001
rLES (s) 10.39 2.97 9.99 2.10 = 0.510
lLES (cm) 3.10 1.48 3.28 1.08 = 0.251
pH-metry Time of acid exposure <pH 4 117.79 132.92 43.39 81.76 £ 0.001
Upright acid exposure <pH 4 95.95 114.77 33.74 66.47 £ 0.001
Supine acid exposure <pH 4 22.07 30.39 9.71 20.69 = 0.001
Postprandial acid exposure <pH 4 53.69 57.45 21.00 40.82 £ 0.001
>5 min acid exposure <pH 4 4.56 6.91 0.73 2.02 £ 0.001
Longest acid exposure <pH 4 23.84 51.18 3.74 6.05 £ 0.001
DeMeester score 40.84 52.29 13.11 31.29 £ 0.001
Bilitec Time of bile exposure 26.45 28.64 19.04 29.88 = 0.020
Upright bile exposure 17.41 19.94 15.61 25.48 = 0.095
Supine bile exposure 9.24 14.96 3.50 7.44 = 0.089
Postprandial bile exposure 8.22 10.06 6.43 10.85 = 0.072
>5 min bile exposure 6.63 9.68 2.64 4.47 = 0.008
Longest bile exposure 74.52 94.29 52.07 125.80 = 0.014
After laparoscopic antireflux surgery the pressure of the LES was significantly increased, and the frequency of acid and biliary reflux was
significantly decreased (Non-parametric method – the Mann–Whitney test – was applied).
Abbreviations: lLES = length of lower esophageal sphincter; pLES = pressure of lower esophageal sphincter; rLES = relaxation time of lower
esophageal sphincter.
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endoscopy were excluded from the long-term
analysis.
Before antireflux surgery, SSBE was present in
56 patients and LSBE in 8 patients. Preoperative
histological examinations indicated FM in 11, CM
in 33, IM in 15, and LGD in 5 patients. Postoper-
ative check-up examination demonstrated total
regression of the BM in 10 patients (15.6%). Partial
regression was seen in 9 cases (14.1%), no further
progression in 34 patients (53.1%), and progres-
sion from FM into CM in 4 patients (6.2%) or from
CM into IM in 7 patients (11%), but no case of
dysplastic or malignant transformation was regis-
tered. There was no further progression in the
patients with LGD, and in three of these five patients
the LGD disappeared, leaving only residual IM
(Table III). There was no difference in the length
of the follow-up period between the total regressive
group and the other groups (partial, no change, and
progression). Where we observed the regression of
BE, out of the postoperative functional examina-
tions results of manometry and pH-metry were sig-
nificantly better compared with those groups where
no changes occurred in BE, or progression of
BE was found. We did not find differences among
the groups in the results of postoperative Bilitec,
apart from the results of the longest expositions
(Table IV).
Discussion
We present evidence that laparoscopic Nissen fundo-
plication can appropriately control the reflux disease
in a majority of the patients who underwent unsuc-
cessful medical treatment, and it may inhibit progres-
sion and induce the regression of BM in a significant
proportion of these patients.
Options available for the treatment of BE include
medicinal treatment, endoscopic ablation, antireflux
surgery, and their combination. The advantage of
surgery over medicinal treatment is that it eliminates
not only acid, but also biliary reflux due to the fact
that it restores the functioning of the LES. Since the
first observation by Brand et al., the fact that anti-
reflux surgery can bring about the regression of
Barrett’s mucosa has become well-known. The
results of recent randomized and nonrandomized
studies suggest that successful antireflux surgery
may be more effective than medical therapy with
respect to preventing BE from progression [29–
37]. The most recent meta-analysis concluded that
antireflux surgery is definitely associated with the
regression of BE and/or dysplasia [38]. However,
evidence suggesting that surgery reduces the inci-
dence of adenocarcinoma largely stems from
uncontrolled studies. Several surgical centers have
reported very good overall outcome of laparoscopic
fundoplication in controlling reflux diseases [39,40].
However, a recent Swedish population-based study
has concluded that antireflux surgery cannot be
considered a procedure which prevents the develop-
ment of esophageal or cardiac adenocarcinoma in
individuals with reflux [41]. Postoperative reflux
which persists or repeatedly recurs after unsuccessful
surgery could be one of the reasons for this [42].
Another reason is that it is common in patients with
more severe reflux to undergo surgery after long and
unsuccessful medical treatment, and in these cases
carcinogenesis cannot be prevented [9]. The extent
of the experience of the surgical team could be a third
reason that also significantly influences both the
short-term and the long-term results.
Inflammation is responsible for the development
of BE, but BE would seem to be an indicator of
Table III. Endoscopic and histopathological changes of BE after laparoscopic fundoplication (64 patients).
Complete regression Partial regression No change Progression
Overall group
SSBE (n = 56) 10 (17.9%) 5 (8.9%) 30 (53.6%) 11 (19.6%)**
LSBE (n = 8) 0 4 (50%) 4 (50%) 0
NI* (n = 44) 6 (13.6%) 4 (9.1%) 23 (52.3%) 11 (25%)**
IM (n = 15) 3 (20%) 3 (20%) 9 (60%) 0
LGD (n = 5) 1 (20%) 2 (40%) 2 (40%) 0
Total (n = 64) 10 (15.6%) 9 (14.1%) 34 (53.1%) 11 (17.2%)**
Complete regression of BE was defined as the absence of any visible metaplasia on endoscopy. Partial regression was defined as a regression
from LSBE to SSBE, or a regression from dysplasia to metaplasia, or changes within the metaplastic group (IM>CM>FM). Aggravation of the
disease was defined as changes within the metaplastic group (such as FM<CM<IM), or progression frommetaplasia to dysplasia or from SSBE
to LSBE. Results are expressed as numbers of patients with percentages in parentheses.
*NI, including FM and CM.
**Progression from FM into CM in four patients or from CM into IM in seven patients; no further progression in patients with IM or LGD.
Abbreviations: BE = Barrett’s esophagus; CM = cardiac metaplasia; FM = fundic metaplasia; IM = intestinal metaplasia; LGD = low-
grade dysplasia; LSBE = long segment Barrett’s esophagus; NI = non-intestinal (group); SSBE = short segment Barrett’s esophagus.
18 Z. Simonka et al.
Sc
an
d 
J G
as
tro
en
te
ro
l D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
U
ni
ve
rs
ity
 o
f S
ze
ge
d 
on
 0
1/
17
/1
2
Fo
r p
er
so
na
l u
se
 o
nl
y.
the severity of the reflux rather than a premalignant
condition. In the process of carcinogenesis, the
importance of the functional examinations (manom-
etry, pH-metry, and Bilitec) should be emphasized
besides endoscopic surveillance. In BE, a larger hiatus
hernia, insufficient LES activity, and more severe acid
and biliary reflux were observed relatively frequently.
It points to the importance of a comparatively fre-
quent and aggressive reflux in the tumorgenesis [13].
Patients’ complaints had persisted for more than
5 years on average before surgery was performed. The
severity of BM (intestinal and LGD) did not correlate
with the duration of the disease. Some published data
suggest medical treatment as a possible successful
alternative mode of treatment, but in fact our patients
underwent surgery after a 20-month period of unsuc-
cessful medical treatment on average. In this group of
resistant patients, BM/dysplasia was not decreased
measurably after conservative therapy and/or the
symptoms of reflux persisted. It may, therefore, be
assumed that patients who finally underwent surgery
were resistant to medical treatment and generally had
worse prospects for recovery.
Severe acid-biliary reflux is presumed to be a factor
in the development of LGD. As concerns the three
groups of patients who underwent surgery because of
BE (the NI group, the I group, and D group), biliary
reflux in the D group proved to be the most severe.
However, it could not be confirmed that acid reflux
that is more frequent and more severe plays a prog-
nostically important role in transforming metaplasia
to dysplasia, and that a change in the structure of the
gastro-esophageal junction, i.e. hiatus hernia, lower
LES pressure, shorter relaxation time, or shorter
length of the LES, is more common in LGD.
Our results proved that laparoscopic antireflux
surgery on BE patients with severe reflux had a
low morbidity rate. Properly performed laparoscopic
surgery eliminated the symptoms in a significant
proportion of the patients; furthermore, it could
successfully restore the activity of the gastro-
esophageal junction, and eliminate or decrease
both acid and biliary reflux which can prevent the
further progression of BM. During endoscopic
follow-up, regression was confirmed in 30% of the
cases, the condition remained unchanged in 53%,
and progression was observed in only 17%, all in the
NI metaplasia group. Dysplasia did not develop in
the I group, and further progression (HGD or in situ
carcinoma) did not occur in the LGD.
It must be mentioned, however, that several forms
of metaplasia and dysplasia (e.g. FM, CM and IM,
pancreatic acinar or pancreatic ductal metaplasia, or
even ciliar epithelium, LGD or HGD) and in situ
carcinoma can be present in the esophageal mucosa at
the same time. Our results highlighted the importance
of endoscopic and biopsy follow-up in cases of FM
and CM. After antireflux surgery, new IM was diag-
nosed in 17% of the cases of FM and CM. This
evidently did not indicate the progression of the
disease, but may be a consequence of the heteroge-
neous form of the disease or of the fact that biopsy
samples were not 100% representative. Multiple
biopsy sampling can contribute to a more exact
Table IV. Comparison of the postoperative functional examination and the BE changes (among the three groups: regression, no change,
progression) (64 patients) (Non-parametric method – the Kruskal–Wallis test – was applied).
Groups
Regression (SD) No change (SD) Progression (SD) p Value
Manometry pLES (mmHg) 18.04 (±6.405) 9 (±7.735) 11.02 (±7.815) 0.003
rLES (s) 10.04 (±1.613) 10.03 (±2.831) 9.89 (±4.285) 0.988
lLES (cm) 3.21 (±0.699) 3.14 (±1.424) 2.89 (±1.269) 0.571
pH-metry Time of acid exposure <pH 4 23.77 (±25.21) 105.29 (±89.191) 112.2 (±82.974) < 0.001
Upright acid exposure <pH 4 21.23 (±24.1229) 79.79 (±67.776) 87.9 (±74.929) 0.002
Supine acid exposure <pH 4 2.62 (±3.595) 25.75 (±33.216) 24.6 (±21.798) 0.002
Postprandial acid exposure <pH 4 12.42 (±16.649) 48.63 (±46.04) 61.3 (±53.506) 0.009
>5 min acid exposure <pH 4 0 (±0) 5.46 (±8.495) 5.1 (±5.607) < 0.001
Longest acid exposure <pH 4 1.38 (±1.557) 19.33 (±27.223) 19.6 (±15.82) < 0.001
DeMeester score 3.52 (±3.617) 40.88 (±51.37) 43.089 (±6.094) < 0.001
Bilitec Time of bile exposure 4.75 (±6.292) 32.05 (±34.861) 23 (±28.605) 0.097
Upright bile exposure 4 (±4.83) 19.21 (±22.062) 15.89 (±18.395) 0.143
Supine bile exposure 0.75 (±1.5) 13.05 (±19.478) 7.44 (±12.69) 0.295
Postprandial bile exposure 1 (±1.414) 8.11 (±10.954) 7.89 (±10.55) 0.117
>5 min bile exposure 0.75 (±1.5) 9.05 (±13.206) 6.33 (±9.206) 0.138
Longest bile exposure 3.25 (±5.188) 81.72 (±99.8) 72.78 (±93.641) 0.050
Abbreviations: BE = Barrett’s esophagus; lLES = length of lower esophageal sphincter; pLES = pressure of lower esophageal sphincter;
rLES = relaxation time of lower esophageal sphincter.
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diagnosis of the state of the disease, but it can reveal
the current state in only a small area, thus making
the correct diagnosis and treatment more difficult.
Regression after surgery has been reported in 35–60%
of patients with SSBE, whereas its regression is
uncommon in LSBE [15,16,30,37,43]. Our results
revealed that antireflux surgery could reduce BM in
both SSBE and LSBE.
Conclusion
Our results highlighted the importance of the cases of
FM and CM, which can also transform into IM.
Results reported here suggest that laparoscopic Nis-
sen fundoplication is a good therapeutic option for
patients with BE after failed medical treatment. Tech-
nically correct antireflux surgery after unsuccessful
medical treatment can ensure a symptom-free state
in a majority of the patients and may result in the
regression of BM. The evaluation of our results and
the conclusions that can be drawn are limited by the
retrospective nature of our study and the limited num-
ber of patients. To determine whether laparoscopic
Nissen fundoplication can halt the progression of BE
and prevent the development of adenocarcinoma in the
long term, regular endoscopic follow-up and functional
examinations should be performed in view of the
slowness of the process of carcinogenesis.
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